Analysts
Heidelberg Pharma AG is followed by the analysts listed below.
| Pareto Securities AS Equity Research Dennis Berzhanin Gräfstrasse 97, 60487 Frankfurt am Main Telefon: +49 (0) 69 / 58997-434 eMail: This email address is being protected from spambots. You need JavaScript enabled to view it. |
EQUI.TS GmbH Thomas Schießle Am Schieferstein 1, 60435 Frankfurt am Main Telefon: +49 (0)69 95 45 43 60 eMail: This email address is being protected from spambots. You need JavaScript enabled to view it. http://www.equits.com/research-reports |
| Baader Helvea AG Equity Research Bruno Bulic, Ph.D. Talstrasse 9 8001 Zurich, Switzerland +41 43 388 9225 eMail: This email address is being protected from spambots. You need JavaScript enabled to view it. |
| Analyst | Date | Valuation | Recommendation |
| Pareto Securities AS | 11.04.2019 | € 4.10 per share | Buy |
| EQUI.TS GmbH | 19.10.2018 | € 5.02 per share | Buy |
| Baader Helvea | 09/2018 | € 4.40 per share | Buy |
The entire contents of these reports is solely attributable to the authors. Heidelberg Pharma AG accepts no responsibility for the validity of the statements contained in these reports, nor do these statements necessarily correspond to the views of the company.
Please contact the institution to request copies of the reports.